The military health system was one of the more consistent payers of weight-loss drugs, while civilian employers were cutting benefits for them—kinda, but not really.

Yes, TRICARE will pay for Wegovy in 2026, but only after prior authorization for chronic weight management. Criteria are based on the FDA label: BMI of 30 or greater, or 27 or greater if there is at least one weight-related condition; and TRICARE is looking for evidence of lifestyle modifications. The standard channels are used for fills, but a wrinkle to this is that weight-loss GLP-1s may not be available at the MTF pharmacy, and TRICARE Pharmacy Home Delivery (around $38 for a formulary brand for 90 days) is a reliable alternative. The heart-protection approval opens up a second covered lane for beneficiaries who have cardiovascular disease.

The following is the channel strategy, prior authorization file, costs by beneficiary category, and renewal rules.

TRICARE's Weight-Management Coverage, Explained

As a “pharmacy benefit,” TRICARE provides anti-obesity drugs when clinical criteria are met, whereas numerous civilian plans opted out of providing coverage for the category altogether in 2026. Wegovy is processed for prior authorization based on the FDA label: BMI of 30 or higher, or between 27 and 29.9 with a weight-related medical condition like hypertension, dyslipidemia, type 2 diabetes or sleep apnea.

This will be followed by a request for documentation of a baseline weight and BMI, the qualifying comorbidity (if applicable), and documentation of lifestyle modification attempts (diet and activity counseling notes will suffice). Renewals are based on the usual criteria of weight loss from baseline, typically the common 5-percent guideline, so weigh-ins should be included in your record from the initial fill. 

The Channel Strategy: Why Home Delivery Wins

TRICARE's three-channel pricing structure pays for routing maintenance meds appropriately. Formulary drugs are available at $0 at military treatment facilities, but are typically not available in the pharmacy so contact before assuming. Formulary brands are provided reliably from TRICARE pharmacy Home Delivery which provides 90-day supplies for approximately $38 (about $13 per month). The most expensive option over a year is “convenience” – retail network pharmacies – that cost approximately $43 per 30-day fill for brand drugs.

All active duty personnel pay $0 at each of the channels for covered medications. Copays above are applicable to retirees and family members and will be updated as TRICARE's fee schedule changes every year – please check the TRICARE pharmacy page for current copay amounts. 

The Cardiovascular Lane for Military Retirees

The March 2024 FDA approval for Wegovy to treat cardiovascular disease (CVD) in adults with a body mass index (BMI) of 27 or higher has a different documentation logic: cardiac documentation replaces the emphasis on the weight management program.

It is important for TRICARE for Life members (Medicare-eligible retirees) to know the coordination: Medicare Part D pays first when members enroll in Medicare, the cardiovascular pathway is available today, and Medicare GLP-1 Bridge pilot for Wegovy weight management will take effect on July 1, 2026, with $50 monthly copay caps, according to NPR. Secondary care is generally covered by TRICARE, so the cost of the care is nominal, if any. 

If You're Denied, and the Self-Pay Bridge

When TRICARE denies, they typically state correctable issues, such as missing BMI documentation, lack of evidence for comorbidities 27 to 29.9, and/or lack of evidence for lifestyle modification. If a complete file is still denied, resubmit and appeal using Express Scripts and TRICARE's formal process; objective criteria makes documented cases strong.

Paperwork will work out, but NovoCare Pharmacy does sell Wegovy for about $499 per month and the federal TrumpRx channel now lists semaglutide at about $350 as it is brought on line over the next several years up to 2026. Self-pay is a stepping-stone, not the end; a covered TRICARE fill is a better rate than any cash plan ($13 to $43 per month). 

Frequently Asked Questions

Yes, with prior authorization requiring a BMI of 30 or higher, or 27 to 29.9 with a weight-related condition like hypertension or sleep apnea, plus documented lifestyle-modification efforts. Renewals require meaningful weight loss from baseline. TRICARE remained a reliable payer in 2026 while many civilian plans cut the category.

Active duty members pay $0 at all channels. Retirees and family members pay about $38 for a 90-day home delivery supply (roughly $13 monthly) or about $43 per 30 days at retail network pharmacies. Military pharmacies dispense free but frequently don't stock weight-loss GLP-1s; call ahead.

Baseline weight and BMI, the qualifying weight-related condition for BMI 27 to 29.9 cases, and evidence of diet and activity counseling or lifestyle-modification efforts. Your prescriber submits through Express Scripts, with decisions typically inside a few days. Keep weigh-ins documented for the renewal's weight-loss benchmark.

Yes, with Medicare Part D paying primary where enrolled: the cardiovascular indication is covered today for heart patients, and the Medicare GLP-1 Bridge pilot covers weight management from July 1, 2026 with $50 monthly copay caps. TRICARE wraps secondary, typically minimizing remaining out-of-pocket costs.

Stocking, not coverage. Military treatment facility pharmacies prioritize their local formulary and frequently don't carry weight-loss GLP-1s. Transfer the prescription to TRICARE Pharmacy Home Delivery for the dependable 90-day channel at about $38, or use a retail network pharmacy; the prior authorization follows the prescription across channels.